After receiving multiple adverse events reports, the FDA wrote a letter to providers urging for heightened patient monitoring. Here’s what you should know. 1. Providers reported two adverse events.
The US Food and Drug Administration (FDA) on Thursday sent a letter to health care providers noting the receipt of dozens of reports for two different types of adverse events linked to fluid-filled ...
Add Yahoo as a preferred source to see more of our stories on Google. Recently, Louisiana legislators voted on House Bill 581, which is aimed at prohibiting the intentional release of inflated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results